Drug intelligence / Profile preview

birch pollen extract

Development stage
Unknown
Lead developer
ALK Abelló
Administration
Sublingual
01

Overview

Birch pollen extract is a standardized allergenic preparation derived from the pollen of the white birch tree (Betula verrucosa). It is primarily used in allergen immunotherapy (AIT) for the treatment and prevention of allergic rhinitis and rhinoconjunctivitis caused by sensitization to birch or related tree pollens. The mechanism of action involves gradual exposure to controlled doses of birch allergens to induce immune tolerance and reduce allergic symptoms. This therapy can be administered as sublingual tablets or drops (SLIT), or as subcutaneous injections (SCIT). Clinical trials have demonstrated that birch pollen extract immunotherapy significantly reduces allergy symptoms and medication use during the tree pollen season and may provide long-term benefits by reducing new-onset asthma risk[4][5][6][10]. Major commercial products include ITULATEK (ALK), Staloral Birch (Stallergenes Greer), and others.

Brand names
ITULATEKStaloral BirchOralair BirchSTALORAL Birch 300 IR
Other names
white birch allergen extractBetula verrucosa pollen extractBet v 1rBet v 1
02

Targets

A. annua-specific IgE (Artemisia annua-specific immunoglobulin E)Major histocompatibility complex class II-Bet v 1 peptide complex

Beyond the preview

Go deeper on birch pollen extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on birch pollen extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call